Elixinol Wellness (Australia) Performance
EXL Stock | 0.04 0 2.27% |
On a scale of 0 to 100, Elixinol Wellness holds a performance score of 7. The firm shows a Beta (market volatility) of 0.4, which means possible diversification benefits within a given portfolio. As returns on the market increase, Elixinol Wellness' returns are expected to increase less than the market. However, during the bear market, the loss of holding Elixinol Wellness is expected to be smaller as well. Please check Elixinol Wellness' downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Elixinol Wellness' price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Elixinol Wellness Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Elixinol Wellness unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:8 | Last Split Date 2024-12-02 |
1 | Elixinol Wellness Announces Lapse of Performance Rights - TipRanks | 01/07/2025 |
Begin Period Cash Flow | 2.9 M |
Elixinol |
Elixinol Wellness Relative Risk vs. Return Landscape
If you would invest 3.20 in Elixinol Wellness Limited on October 20, 2024 and sell it today you would earn a total of 1.10 from holding Elixinol Wellness Limited or generate 34.37% return on investment over 90 days. Elixinol Wellness Limited is generating 0.8869% of daily returns assuming 9.068% volatility of returns over the 90 days investment horizon. Simply put, 80% of all stocks have less volatile historical return distribution than Elixinol Wellness, and 83% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
Elixinol Wellness Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elixinol Wellness' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Elixinol Wellness Limited, and traders can use it to determine the average amount a Elixinol Wellness' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0978
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | EXL | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
9.07 actual daily | 80 80% of assets are less volatile |
Expected Return
0.89 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Elixinol Wellness is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elixinol Wellness by adding it to a well-diversified portfolio.
Elixinol Wellness Fundamentals Growth
Elixinol Stock prices reflect investors' perceptions of the future prospects and financial health of Elixinol Wellness, and Elixinol Wellness fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elixinol Stock performance.
Return On Equity | -0.87 | ||||
Return On Asset | -0.28 | ||||
Profit Margin | (0.59) % | ||||
Operating Margin | (0.39) % | ||||
Current Valuation | 9.1 M | ||||
Shares Outstanding | 220.82 M | ||||
Price To Book | 1.28 X | ||||
Price To Sales | 0.82 X | ||||
Revenue | 8.27 M | ||||
Gross Profit | 4.13 M | ||||
EBITDA | (6.81 M) | ||||
Net Income | (7.51 M) | ||||
Total Debt | 1.26 M | ||||
Book Value Per Share | 0.01 X | ||||
Cash Flow From Operations | (2.76 M) | ||||
Earnings Per Share | (0.06) X | ||||
Total Asset | 11.71 M | ||||
Retained Earnings | (226.15 M) | ||||
About Elixinol Wellness Performance
Assessing Elixinol Wellness' fundamental ratios provides investors with valuable insights into Elixinol Wellness' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Elixinol Wellness is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Elixinol Wellness is entity of Australia. It is traded as Stock on AU exchange.Things to note about Elixinol Wellness performance evaluation
Checking the ongoing alerts about Elixinol Wellness for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elixinol Wellness help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Elixinol Wellness is way too risky over 90 days horizon | |
Elixinol Wellness has some characteristics of a very speculative penny stock | |
Elixinol Wellness appears to be risky and price may revert if volatility continues | |
Elixinol Wellness has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 8.27 M. Net Loss for the year was (7.51 M) with profit before overhead, payroll, taxes, and interest of 4.13 M. | |
Elixinol Wellness generates negative cash flow from operations | |
About 58.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Elixinol Wellness Announces Lapse of Performance Rights - TipRanks |
- Analyzing Elixinol Wellness' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elixinol Wellness' stock is overvalued or undervalued compared to its peers.
- Examining Elixinol Wellness' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elixinol Wellness' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elixinol Wellness' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elixinol Wellness' stock. These opinions can provide insight into Elixinol Wellness' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Elixinol Stock Analysis
When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.